Form 4 for GH Guardant Health, Inc.
Accepted 2024-11-19 00:00:00 ET · period of report 2024-11-18 · accession 0001576280-24-000287 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-19 | 2024-11-18 | GH | Kalia Kumud | CIO | S - Sale | $29.25 | -7,000 | 17.7K | -28% | -$204.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-18 | S | D | 7,000 | $29.25 | 17,744 | D | — | — | (F1) Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $29.23 to $29.31. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. |